Loading…

Effects of Taurine on Aortic Rings Isolated from Fructose-fed Insulin Resistance Sprague–Dawley Rat are Changed

Purpose To observe and compare the effect of taurine on contractions of aortic rings isolated from normal (NC) and insulin resistance (IR) Sprague–Dawley rats, and to explore its underlying mechanism(s). Methods The IR animal model was made by feeding rats with high fructose diet for 8 weeks. Aortic...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular drugs and therapy 2008-12, Vol.22 (6), p.461-468
Main Authors: Xue, Wenxin, Zhang, Mingsheng, Li, Jie, Wu, Dongmei, Niu, Longgang, Liang, Yueqin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c399t-70f473445a1a78b798b07c625f8b2640d9e88d1941403cc996b092e0396c52193
cites cdi_FETCH-LOGICAL-c399t-70f473445a1a78b798b07c625f8b2640d9e88d1941403cc996b092e0396c52193
container_end_page 468
container_issue 6
container_start_page 461
container_title Cardiovascular drugs and therapy
container_volume 22
creator Xue, Wenxin
Zhang, Mingsheng
Li, Jie
Wu, Dongmei
Niu, Longgang
Liang, Yueqin
description Purpose To observe and compare the effect of taurine on contractions of aortic rings isolated from normal (NC) and insulin resistance (IR) Sprague–Dawley rats, and to explore its underlying mechanism(s). Methods The IR animal model was made by feeding rats with high fructose diet for 8 weeks. Aortic rings were isolated and suspended in a tissue bath, and tensions were recorded isometrically. The effects of taurine on provoked contractions of the rings were assessed in absence or presence of different potassium channel or NO-synthase inhibitors. Results Taurine (20–80 mM) concentration-dependently relaxed precontractions induced by KCl (30 mM) and phenylephrine (1 μM) in NC rings, but enhanced the precontractions in IR rings. Denudation of the endothelium and pretreatment with N G -nitro- l -arginine methylester ester (0.1 mM) reversed the contraction enhancement of taurine to relaxation in IR rings. Tetraethylammonium (10 mM) nearly abolished taurine-induced relaxation of NC rings, and augmented taurine-induced contraction enhancement in IR rings. Iberiotoxin (100 nM) only augmented the contraction enhancement in IR rings. 4-Aminopyridine (1 mM), glibenclamide (10 μM) and indomethacin (10 μM) had no influence on the effect of taurine in both NC and IR rings. Conclusion Taurine enhances contractions in IR aortic rings but relaxes the contractions in normal rat aortic ring; the enhancement is endothelium-dependent and the relaxation is endothelium-independent. TEA-sensitive K + channel may be involved in these actions; BK Ca channel dysfunction and endothelium-derived substances may be related to the contraction enhancement induced by taurine in IR aorta.
doi_str_mv 10.1007/s10557-008-6124-9
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_213846566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1593164971</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-70f473445a1a78b798b07c625f8b2640d9e88d1941403cc996b092e0396c52193</originalsourceid><addsrcrecordid>eNp1kM9qGzEQh0VpaNy0D9BLEYUc1Y60-nsMbtIaAgUnPQutVnI3rFeOtEvIre-QN8yTRMamOfU0oPnmN6MPoU8UvlIA9a1QEEIRAE0kZZyYN2hBhWqIYpy-RQswDEjDQJ6i96XcQZ0xRr9Dp1RXXgNfoPvLGIOfCk4R37o592PAacQXKU-9x-t-3BS8KmlwU-hwzGmLr_Lsp1QCifVlNZZ56Ee8DqUvkxt9wDe77DZzeP779N09DOERr92EXQ54-ceNm9B9QCfRDSV8PNYz9Pvq8nb5k1z_-rFaXlwT3xgzEQWRq4Zz4ahTulVGt6C8ZCLqlkkOnQlad9RwyqHx3hjZ1u8GaIz0glHTnKEvh9xdTvdzKJO9S3Me60rLaKO5FFJWiB4gn1MpOUS7y_3W5UdLwe4d24NjWx3bvWO7D_58DJ7bbeheJ45SK3B-BFzxboi5eunLP46BASYEqxw7cKW2qpr8euH_t78AcGOTTg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213846566</pqid></control><display><type>article</type><title>Effects of Taurine on Aortic Rings Isolated from Fructose-fed Insulin Resistance Sprague–Dawley Rat are Changed</title><source>Springer Nature</source><creator>Xue, Wenxin ; Zhang, Mingsheng ; Li, Jie ; Wu, Dongmei ; Niu, Longgang ; Liang, Yueqin</creator><creatorcontrib>Xue, Wenxin ; Zhang, Mingsheng ; Li, Jie ; Wu, Dongmei ; Niu, Longgang ; Liang, Yueqin</creatorcontrib><description>Purpose To observe and compare the effect of taurine on contractions of aortic rings isolated from normal (NC) and insulin resistance (IR) Sprague–Dawley rats, and to explore its underlying mechanism(s). Methods The IR animal model was made by feeding rats with high fructose diet for 8 weeks. Aortic rings were isolated and suspended in a tissue bath, and tensions were recorded isometrically. The effects of taurine on provoked contractions of the rings were assessed in absence or presence of different potassium channel or NO-synthase inhibitors. Results Taurine (20–80 mM) concentration-dependently relaxed precontractions induced by KCl (30 mM) and phenylephrine (1 μM) in NC rings, but enhanced the precontractions in IR rings. Denudation of the endothelium and pretreatment with N G -nitro- l -arginine methylester ester (0.1 mM) reversed the contraction enhancement of taurine to relaxation in IR rings. Tetraethylammonium (10 mM) nearly abolished taurine-induced relaxation of NC rings, and augmented taurine-induced contraction enhancement in IR rings. Iberiotoxin (100 nM) only augmented the contraction enhancement in IR rings. 4-Aminopyridine (1 mM), glibenclamide (10 μM) and indomethacin (10 μM) had no influence on the effect of taurine in both NC and IR rings. Conclusion Taurine enhances contractions in IR aortic rings but relaxes the contractions in normal rat aortic ring; the enhancement is endothelium-dependent and the relaxation is endothelium-independent. TEA-sensitive K + channel may be involved in these actions; BK Ca channel dysfunction and endothelium-derived substances may be related to the contraction enhancement induced by taurine in IR aorta.</description><identifier>ISSN: 0920-3206</identifier><identifier>EISSN: 1573-7241</identifier><identifier>DOI: 10.1007/s10557-008-6124-9</identifier><identifier>PMID: 18612804</identifier><identifier>CODEN: CDTHET</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject><![CDATA[4-Aminopyridine - pharmacology ; Acetylcholine - pharmacology ; Administration, Oral ; Animals ; Aorta - drug effects ; Aorta - pathology ; Biological and medical sciences ; Blood Glucose - drug effects ; Blood Pressure ; Cardiology ; Cardiovascular system ; Cyclooxygenase Inhibitors - administration & dosage ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Drug Synergism ; Endothelium, Vascular - injuries ; Endothelium-Dependent Relaxing Factors - pharmacology ; Fructose - administration & dosage ; Fructose - adverse effects ; Glyburide - pharmacology ; In Vitro Techniques ; Indomethacin - administration & dosage ; Insulin - blood ; Insulin Resistance ; Male ; Medical sciences ; Medicine ; Medicine & Public Health ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric Oxide - blood ; Nitric Oxide Donors - pharmacology ; Nitroprusside - pharmacology ; Peptides - pharmacology ; Pharmacology. Drug treatments ; Phenylephrine - antagonists & inhibitors ; Phenylephrine - pharmacology ; Potassium Channel Blockers - classification ; Potassium Channel Blockers - pharmacology ; Potassium Chloride - antagonists & inhibitors ; Potassium Chloride - pharmacology ; Rats ; Rats, Sprague-Dawley ; Taurine - antagonists & inhibitors ; Taurine - pharmacology ; Tetraethylammonium - pharmacology ; Vasoconstriction - drug effects ; Vasodilation - drug effects]]></subject><ispartof>Cardiovascular drugs and therapy, 2008-12, Vol.22 (6), p.461-468</ispartof><rights>Springer Science+Business Media, LLC 2008</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-70f473445a1a78b798b07c625f8b2640d9e88d1941403cc996b092e0396c52193</citedby><cites>FETCH-LOGICAL-c399t-70f473445a1a78b798b07c625f8b2640d9e88d1941403cc996b092e0396c52193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20902552$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18612804$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xue, Wenxin</creatorcontrib><creatorcontrib>Zhang, Mingsheng</creatorcontrib><creatorcontrib>Li, Jie</creatorcontrib><creatorcontrib>Wu, Dongmei</creatorcontrib><creatorcontrib>Niu, Longgang</creatorcontrib><creatorcontrib>Liang, Yueqin</creatorcontrib><title>Effects of Taurine on Aortic Rings Isolated from Fructose-fed Insulin Resistance Sprague–Dawley Rat are Changed</title><title>Cardiovascular drugs and therapy</title><addtitle>Cardiovasc Drugs Ther</addtitle><addtitle>Cardiovasc Drugs Ther</addtitle><description>Purpose To observe and compare the effect of taurine on contractions of aortic rings isolated from normal (NC) and insulin resistance (IR) Sprague–Dawley rats, and to explore its underlying mechanism(s). Methods The IR animal model was made by feeding rats with high fructose diet for 8 weeks. Aortic rings were isolated and suspended in a tissue bath, and tensions were recorded isometrically. The effects of taurine on provoked contractions of the rings were assessed in absence or presence of different potassium channel or NO-synthase inhibitors. Results Taurine (20–80 mM) concentration-dependently relaxed precontractions induced by KCl (30 mM) and phenylephrine (1 μM) in NC rings, but enhanced the precontractions in IR rings. Denudation of the endothelium and pretreatment with N G -nitro- l -arginine methylester ester (0.1 mM) reversed the contraction enhancement of taurine to relaxation in IR rings. Tetraethylammonium (10 mM) nearly abolished taurine-induced relaxation of NC rings, and augmented taurine-induced contraction enhancement in IR rings. Iberiotoxin (100 nM) only augmented the contraction enhancement in IR rings. 4-Aminopyridine (1 mM), glibenclamide (10 μM) and indomethacin (10 μM) had no influence on the effect of taurine in both NC and IR rings. Conclusion Taurine enhances contractions in IR aortic rings but relaxes the contractions in normal rat aortic ring; the enhancement is endothelium-dependent and the relaxation is endothelium-independent. TEA-sensitive K + channel may be involved in these actions; BK Ca channel dysfunction and endothelium-derived substances may be related to the contraction enhancement induced by taurine in IR aorta.</description><subject>4-Aminopyridine - pharmacology</subject><subject>Acetylcholine - pharmacology</subject><subject>Administration, Oral</subject><subject>Animals</subject><subject>Aorta - drug effects</subject><subject>Aorta - pathology</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - drug effects</subject><subject>Blood Pressure</subject><subject>Cardiology</subject><subject>Cardiovascular system</subject><subject>Cyclooxygenase Inhibitors - administration &amp; dosage</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Synergism</subject><subject>Endothelium, Vascular - injuries</subject><subject>Endothelium-Dependent Relaxing Factors - pharmacology</subject><subject>Fructose - administration &amp; dosage</subject><subject>Fructose - adverse effects</subject><subject>Glyburide - pharmacology</subject><subject>In Vitro Techniques</subject><subject>Indomethacin - administration &amp; dosage</subject><subject>Insulin - blood</subject><subject>Insulin Resistance</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric Oxide - blood</subject><subject>Nitric Oxide Donors - pharmacology</subject><subject>Nitroprusside - pharmacology</subject><subject>Peptides - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenylephrine - antagonists &amp; inhibitors</subject><subject>Phenylephrine - pharmacology</subject><subject>Potassium Channel Blockers - classification</subject><subject>Potassium Channel Blockers - pharmacology</subject><subject>Potassium Chloride - antagonists &amp; inhibitors</subject><subject>Potassium Chloride - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Taurine - antagonists &amp; inhibitors</subject><subject>Taurine - pharmacology</subject><subject>Tetraethylammonium - pharmacology</subject><subject>Vasoconstriction - drug effects</subject><subject>Vasodilation - drug effects</subject><issn>0920-3206</issn><issn>1573-7241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp1kM9qGzEQh0VpaNy0D9BLEYUc1Y60-nsMbtIaAgUnPQutVnI3rFeOtEvIre-QN8yTRMamOfU0oPnmN6MPoU8UvlIA9a1QEEIRAE0kZZyYN2hBhWqIYpy-RQswDEjDQJ6i96XcQZ0xRr9Dp1RXXgNfoPvLGIOfCk4R37o592PAacQXKU-9x-t-3BS8KmlwU-hwzGmLr_Lsp1QCifVlNZZ56Ee8DqUvkxt9wDe77DZzeP779N09DOERr92EXQ54-ceNm9B9QCfRDSV8PNYz9Pvq8nb5k1z_-rFaXlwT3xgzEQWRq4Zz4ahTulVGt6C8ZCLqlkkOnQlad9RwyqHx3hjZ1u8GaIz0glHTnKEvh9xdTvdzKJO9S3Me60rLaKO5FFJWiB4gn1MpOUS7y_3W5UdLwe4d24NjWx3bvWO7D_58DJ7bbeheJ45SK3B-BFzxboi5eunLP46BASYEqxw7cKW2qpr8euH_t78AcGOTTg</recordid><startdate>20081201</startdate><enddate>20081201</enddate><creator>Xue, Wenxin</creator><creator>Zhang, Mingsheng</creator><creator>Li, Jie</creator><creator>Wu, Dongmei</creator><creator>Niu, Longgang</creator><creator>Liang, Yueqin</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20081201</creationdate><title>Effects of Taurine on Aortic Rings Isolated from Fructose-fed Insulin Resistance Sprague–Dawley Rat are Changed</title><author>Xue, Wenxin ; Zhang, Mingsheng ; Li, Jie ; Wu, Dongmei ; Niu, Longgang ; Liang, Yueqin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-70f473445a1a78b798b07c625f8b2640d9e88d1941403cc996b092e0396c52193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>4-Aminopyridine - pharmacology</topic><topic>Acetylcholine - pharmacology</topic><topic>Administration, Oral</topic><topic>Animals</topic><topic>Aorta - drug effects</topic><topic>Aorta - pathology</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - drug effects</topic><topic>Blood Pressure</topic><topic>Cardiology</topic><topic>Cardiovascular system</topic><topic>Cyclooxygenase Inhibitors - administration &amp; dosage</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Synergism</topic><topic>Endothelium, Vascular - injuries</topic><topic>Endothelium-Dependent Relaxing Factors - pharmacology</topic><topic>Fructose - administration &amp; dosage</topic><topic>Fructose - adverse effects</topic><topic>Glyburide - pharmacology</topic><topic>In Vitro Techniques</topic><topic>Indomethacin - administration &amp; dosage</topic><topic>Insulin - blood</topic><topic>Insulin Resistance</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric Oxide - blood</topic><topic>Nitric Oxide Donors - pharmacology</topic><topic>Nitroprusside - pharmacology</topic><topic>Peptides - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenylephrine - antagonists &amp; inhibitors</topic><topic>Phenylephrine - pharmacology</topic><topic>Potassium Channel Blockers - classification</topic><topic>Potassium Channel Blockers - pharmacology</topic><topic>Potassium Chloride - antagonists &amp; inhibitors</topic><topic>Potassium Chloride - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Taurine - antagonists &amp; inhibitors</topic><topic>Taurine - pharmacology</topic><topic>Tetraethylammonium - pharmacology</topic><topic>Vasoconstriction - drug effects</topic><topic>Vasodilation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xue, Wenxin</creatorcontrib><creatorcontrib>Zhang, Mingsheng</creatorcontrib><creatorcontrib>Li, Jie</creatorcontrib><creatorcontrib>Wu, Dongmei</creatorcontrib><creatorcontrib>Niu, Longgang</creatorcontrib><creatorcontrib>Liang, Yueqin</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Cardiovascular drugs and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xue, Wenxin</au><au>Zhang, Mingsheng</au><au>Li, Jie</au><au>Wu, Dongmei</au><au>Niu, Longgang</au><au>Liang, Yueqin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Taurine on Aortic Rings Isolated from Fructose-fed Insulin Resistance Sprague–Dawley Rat are Changed</atitle><jtitle>Cardiovascular drugs and therapy</jtitle><stitle>Cardiovasc Drugs Ther</stitle><addtitle>Cardiovasc Drugs Ther</addtitle><date>2008-12-01</date><risdate>2008</risdate><volume>22</volume><issue>6</issue><spage>461</spage><epage>468</epage><pages>461-468</pages><issn>0920-3206</issn><eissn>1573-7241</eissn><coden>CDTHET</coden><abstract>Purpose To observe and compare the effect of taurine on contractions of aortic rings isolated from normal (NC) and insulin resistance (IR) Sprague–Dawley rats, and to explore its underlying mechanism(s). Methods The IR animal model was made by feeding rats with high fructose diet for 8 weeks. Aortic rings were isolated and suspended in a tissue bath, and tensions were recorded isometrically. The effects of taurine on provoked contractions of the rings were assessed in absence or presence of different potassium channel or NO-synthase inhibitors. Results Taurine (20–80 mM) concentration-dependently relaxed precontractions induced by KCl (30 mM) and phenylephrine (1 μM) in NC rings, but enhanced the precontractions in IR rings. Denudation of the endothelium and pretreatment with N G -nitro- l -arginine methylester ester (0.1 mM) reversed the contraction enhancement of taurine to relaxation in IR rings. Tetraethylammonium (10 mM) nearly abolished taurine-induced relaxation of NC rings, and augmented taurine-induced contraction enhancement in IR rings. Iberiotoxin (100 nM) only augmented the contraction enhancement in IR rings. 4-Aminopyridine (1 mM), glibenclamide (10 μM) and indomethacin (10 μM) had no influence on the effect of taurine in both NC and IR rings. Conclusion Taurine enhances contractions in IR aortic rings but relaxes the contractions in normal rat aortic ring; the enhancement is endothelium-dependent and the relaxation is endothelium-independent. TEA-sensitive K + channel may be involved in these actions; BK Ca channel dysfunction and endothelium-derived substances may be related to the contraction enhancement induced by taurine in IR aorta.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>18612804</pmid><doi>10.1007/s10557-008-6124-9</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0920-3206
ispartof Cardiovascular drugs and therapy, 2008-12, Vol.22 (6), p.461-468
issn 0920-3206
1573-7241
language eng
recordid cdi_proquest_journals_213846566
source Springer Nature
subjects 4-Aminopyridine - pharmacology
Acetylcholine - pharmacology
Administration, Oral
Animals
Aorta - drug effects
Aorta - pathology
Biological and medical sciences
Blood Glucose - drug effects
Blood Pressure
Cardiology
Cardiovascular system
Cyclooxygenase Inhibitors - administration & dosage
Disease Models, Animal
Dose-Response Relationship, Drug
Drug Synergism
Endothelium, Vascular - injuries
Endothelium-Dependent Relaxing Factors - pharmacology
Fructose - administration & dosage
Fructose - adverse effects
Glyburide - pharmacology
In Vitro Techniques
Indomethacin - administration & dosage
Insulin - blood
Insulin Resistance
Male
Medical sciences
Medicine
Medicine & Public Health
NG-Nitroarginine Methyl Ester - pharmacology
Nitric Oxide - blood
Nitric Oxide Donors - pharmacology
Nitroprusside - pharmacology
Peptides - pharmacology
Pharmacology. Drug treatments
Phenylephrine - antagonists & inhibitors
Phenylephrine - pharmacology
Potassium Channel Blockers - classification
Potassium Channel Blockers - pharmacology
Potassium Chloride - antagonists & inhibitors
Potassium Chloride - pharmacology
Rats
Rats, Sprague-Dawley
Taurine - antagonists & inhibitors
Taurine - pharmacology
Tetraethylammonium - pharmacology
Vasoconstriction - drug effects
Vasodilation - drug effects
title Effects of Taurine on Aortic Rings Isolated from Fructose-fed Insulin Resistance Sprague–Dawley Rat are Changed
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T20%3A19%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Taurine%20on%20Aortic%20Rings%20Isolated%20from%20Fructose-fed%20Insulin%20Resistance%20Sprague%E2%80%93Dawley%20Rat%20are%20Changed&rft.jtitle=Cardiovascular%20drugs%20and%20therapy&rft.au=Xue,%20Wenxin&rft.date=2008-12-01&rft.volume=22&rft.issue=6&rft.spage=461&rft.epage=468&rft.pages=461-468&rft.issn=0920-3206&rft.eissn=1573-7241&rft.coden=CDTHET&rft_id=info:doi/10.1007/s10557-008-6124-9&rft_dat=%3Cproquest_cross%3E1593164971%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c399t-70f473445a1a78b798b07c625f8b2640d9e88d1941403cc996b092e0396c52193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=213846566&rft_id=info:pmid/18612804&rfr_iscdi=true